Clinical Trials Logo

Clinical Trial Summary

The goal of this double-blinded, randomized, crossover trial is to investigate the effects of NMN supplementation on liver function, liver fat content and lipid metabolism in healthy young subjects with acute binge drink. The main questions it aims to answer are: 1. if NMN administration could accelerate alcohol metabolism and alleviate hangover symptom; 2. if NMN administration could alleviate alcohol-induced liver injury and hepatic steatosis.


Clinical Trial Description

The goal of this double-blinded, randomized, crossover trial is to investigate the effects of NMN supplementation on liver function, liver fat content and lipid metabolism in healthy young subjects with acute binge drink. The main questions it aims to answer are: 1. if NMN administration could accelerate alcohol metabolism and alleviate hangover symptom; 2. if NMN administration could alleviate alcohol-induced liver injury and hepatic steatosis. Participants will be randomized into two groups (n=20), and take 4 NMN capsules (250mg/capsule) or 4 placebo capsules (maltodextrin), respectively. 15 minutes later, they are successively provided with same breakfast and then vodka with a dose of 1g/kg body weight. Venous blood are collected at 0h, 1h, 2h, 3h, 4h, 8h, 12h and 24h from each subject, respectively. In addition, nuclear magnetic resonance imaging (MRI) are taken at 0h, 4h and 24h after alcohol intake. After a 7-day washout period, volunteers are crossed over to another alternative group to receive the corresponding capsules and the test protocol repeats twice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05882214
Study type Interventional
Source Zhejiang Chinese Medical University
Contact
Status Active, not recruiting
Phase N/A
Start date March 1, 2024
Completion date July 18, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05480696 - Soluble Fibre Supplementation in NAFLD Phase 1
Completed NCT05124847 - TREating Pediatric Obesity N/A
Recruiting NCT05499585 - Treating Pediatric NAFLD With Nutrition N/A
Completed NCT03717935 - Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS N/A
Active, not recruiting NCT02493153 - Hepatic Steatosis After Cholecystectomy N/A
Active, not recruiting NCT05654051 - The SLIM LIVER Study Phase 2
Completed NCT03334214 - Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes Phase 2
Enrolling by invitation NCT02816814 - Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women N/A
Active, not recruiting NCT03587727 - Hepatic Mitochondrial Function in Youth
Not yet recruiting NCT05935826 - Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study) N/A
Not yet recruiting NCT06363617 - Implementation of the Fatty Liver Index in Primary Care N/A
Recruiting NCT03142698 - Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis N/A
Completed NCT00480922 - Effects of a Low Glycemic Load Diet on Fatty Liver in Children N/A
Not yet recruiting NCT05871749 - Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
Recruiting NCT05897073 - Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity N/A
Completed NCT03961516 - Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
Completed NCT04180631 - Quantitative US for Hepatic Steatosis N/A
Terminated NCT00845845 - Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH) Phase 2
Completed NCT02814240 - Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging N/A
Completed NCT05265026 - Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic Steatosis N/A